Point-of-Care Diagnostics World Congress

Bringing together leaders from both academia and industry, this conference will discuss the expanding Point-of-Care Diagnostics field and provide the most up-to-date presentations and networking opportunities.

This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval. Experts in their field will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry to discuss problems, highlight solutions and facilitating collaborations.

Agenda Topics:
- Commercial Trends for POC Diagnostics
* Cancer/Oncology POC Commercialization
* Cardiovascular Disease POC Commercialization
* Infectious Disease POC Commercialization
* Investor Trends in POC Diagnostics
- Emerging Technologies and Emerging Companies in the POC Space
* Convergence of POC with Other Spaces
- POC in Cancer/Oncology Testing Space
* Imaging and Early Cancer Detection
* POC in Companion Diagnostics (CDx)
- POC in Cardiovascular Disease Testing Space
- POC in Global Health [An International Perspective]
- POC in Infectious Disease Applications
- Regulatory and Licensing Hurdles
- Smartphone and Mobile Diagnostics
* Health Safety and Environmental Monitoring
* Home Health/Telehealth

+ show speakers and program
Keynote Speakers:
- Yolanda Cillo, Medical Director, Abbott Diagnostics
- Anne F Grobler, Professor, North-West University South Africa
- Michelle Khine, Associate Professor, Dept. of Biomedical Engineering, University of California-Irvine
- Gene Walther, Deputy Director, Diagnostics, Discovery, Global Health Program, Bill & Melinda Gates Foundation
- Alan Wright, Chief Medical Officer, Roche Diagnostics

Other Speakers:
- Utkan Demirci, Associate Professor, Stanford University School of Medicine
- Bernhard Weigl, Portfolio Leader NCD Diagnostics, PATH and University of Washington Dept. Bioengineering
- Logan Liu, Associate Professor, University of Illinois
- Kevin Plaxco, Professor, University of California-Santa Barbara
- Brian Cunningham, Professor of Bioengineering, Interim Director, Micro and Nanotechnology Laboratory, University of Illinois at Urbana-Champaign
-Rashid Bashir, Abel Bliss Professor, Head Bioengineering, University of Illinois at Urbana Champaign
- Craig Lehmann, Dean/Professor, Stony Brook University
- Euan McLeod, Research Scholar, Electrical Engineering, University of California Los Angeles
- Henk Schallig, Research Coordinator, Koninklijk Instituut Voor de Tropen
- Marya Lieberman, Associate Professor, University of Notre Dame
- Joel Ehrenkranz, Chief Medical Officer, I-calQ LLC
- Ryan Bailey, Associate Professor of Chemistry, University of Illinois at Urbana-Champaign
- James Boiani, Senior Counsel, Epstein Becker & Green, P.C.
- Vadim Backman, Walter Dill Scott Professor of Biomedical Engineering, Northwestern University
- James Herron, Associate Professor, University of Utah
- Pramod Gaur, Vice President, TeleHealth, Optum, A United Health Group Company
- Nimmi Ramanujam, Professor and Director, Global Women's Health Technologies, Duke Global Health Institute
- Adam Wax, Theodore Kennedy Professor, Duke University
- Ken Yale, Vice President of Clinical Solutions, ActiveHealth Management-An Aetna Company
- Robert Kwiatkowski, Vice President, Infectious Disease R&D, Cepheid

18 Sep - 19 Sep 2014

San Diego
United States of America
meeting website